News | August 17, 2023
Lupin Launches Tiotropium Dry Powder for Inhaler for COPD in US
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Newcastle University’s Dr Srikanth Ramaswamy has been announced as one of six new Fellows selected for the 2023 Lister prize
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Subscribe To Our Newsletter & Stay Updated
